GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I’d seen in the stock before that. When investing, your capital is at risk ...

GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for 2025 and a rival to Pfizer's first-to-market Penbraya. The shot protects ...

Wave Life Sciences Ltd . (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, has been making significant ...

Shares in GSK lost 8% of their value today in the wake of the analyst comments, while Sanofi fell 3% and Haleon was down 6%, collectively wiping tens of billions of dollars off their valuations.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

In other recent news, GSK plc announced that the US Food and Drug Administration has accepted the Biologics License Application for depemokimab, targeting asthma and chronic rhinosinusitis with ...

Ex-Intel head says TSMC’s new investment will not resurrect US chip sector Read the Market Summary Here:- Highlighted with 142 tables and 105 figures, this 228-page report ?Global Pharmaceutical ...

This report focuses on identifying opportunities and strategies for investing in the global pain management drugs market within the forecast period. It provides a complete analysis of the global ...

Investing.com -- Shares of Roblox Inc (NYSE:RBLX) climbed 3.5% today after the company announced the introduction of a new video advertising format and a partnership with tech giant Google ...

Investing.com -- Shares of Hims & Hers Health Inc. (NYSE: HIMS) climbed 8% after announcing its plan to sell Eli Lilly (NYSE:LLY)’s diabetes and weight-loss drug Zepbound on its telehealth platform.